Consolidated Statement Of Income

HISAMITSU PHARMACEUTICAL CO.,INC. - Filing #7720036

Concept 2018-03-01 to
2018-08-31
2017-03-01 to
2017-08-31
Consolidated statement of income
Statement of income
Net sales
69,384,000,000 JPY
73,463,000,000 JPY
Ordinary income
Other operating income
Share of profit of entities accounted for using equity method
19,000,000 JPY
JPY
Cost of sales
26,130,000,000 JPY
27,584,000,000 JPY
Operating expenses
Selling, general and administrative expenses
32,024,000,000 JPY
33,249,000,000 JPY
Operating expenses
Ordinary expenses
Other operating expenses
Share of loss of entities accounted for using equity method
JPY
399,000,000 JPY
Net sales
Gross profit (loss)
43,253,000,000 JPY
45,878,000,000 JPY
Operating profit (loss)
11,229,000,000 JPY
12,629,000,000 JPY
Ordinary profit (loss)
12,012,000,000 JPY
12,869,000,000 JPY
Operating expenses
Research and development expenses
6,329,000,000 JPY
7,935,000,000 JPY
Extraordinary income
218,000,000 JPY
487,000,000 JPY
Non-operating income
Dividend income
422,000,000 JPY
403,000,000 JPY
Interest income
278,000,000 JPY
180,000,000 JPY
Other
186,000,000 JPY
248,000,000 JPY
Non-operating income
923,000,000 JPY
849,000,000 JPY
Cost of sales
Selling, general and administrative expenses
Advertising expenses
6,229,000,000 JPY
5,774,000,000 JPY
Extraordinary losses
10,000,000 JPY
2,000,000 JPY
Loss on disposal of non-current assets
10,000,000 JPY
2,000,000 JPY
Non-operating expenses
139,000,000 JPY
609,000,000 JPY
Interest expenses
5,000,000 JPY
15,000,000 JPY
Non-operating expenses
Other
12,000,000 JPY
10,000,000 JPY
Profit (loss) before income taxes
12,221,000,000 JPY
13,354,000,000 JPY
Gross profit
Extraordinary income
Gain on sale of investment securities
218,000,000 JPY
487,000,000 JPY
Extraordinary losses
Income taxes
2,917,000,000 JPY
3,809,000,000 JPY
Profit (loss)
9,303,000,000 JPY
9,545,000,000 JPY
Profit (loss) attributable to non-controlling interests
145,000,000 JPY
158,000,000 JPY
Profit (loss) attributable to owners of parent
9,158,000,000 JPY
9,386,000,000 JPY
Profit attributable to
Other comprehensive income
Valuation difference on available-for-sale securities
610,000,000 JPY
1,736,000,000 JPY
Foreign currency translation adjustment
-1,653,000,000 JPY
-2,289,000,000 JPY
Share of other comprehensive income of entities accounted for using equity method
-51,000,000 JPY
5,000,000 JPY
Remeasurements of defined benefit plans, net of tax
112,000,000 JPY
131,000,000 JPY
Other comprehensive income
-982,000,000 JPY
-415,000,000 JPY
Comprehensive income
8,321,000,000 JPY
9,129,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
8,208,000,000 JPY
8,984,000,000 JPY
Comprehensive income attributable to non-controlling interests
112,000,000 JPY
145,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.